Home / Italy / CTI Biopharma Corp
CTI Biopharma Corp
No short position is open on this share today.
0.00% of the capital sold short
0 disclosing funds
163 disclosures on record
Evolution of the disclosed total
0%1%
Oct 2025Jan 2026Apr 2026Jul 2026
November 30, 2012 today
Open positions
No fund discloses a short position on this share today. The History of disclosures table lists the ones that existed.
Get the moves on CTI Biopharma Corp by mail.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| December 26, 2012 | The Goldman Sachs Group, Inc. | 1.30% | |
| December 24, 2012 | The Goldman Sachs Group, Inc. | 1.24% | |
| December 21, 2012 | The Goldman Sachs Group, Inc. | 1.19% | |
| December 19, 2012 | The Goldman Sachs Group, Inc. | 0.95% | |
| December 18, 2012 | The Goldman Sachs Group, Inc. | 1.05% | |
| December 12, 2012 | The Goldman Sachs Group, Inc. | 1.15% | |
| December 10, 2012 | The Goldman Sachs Group, Inc. | 1.37% | |
| December 7, 2012 | The Goldman Sachs Group, Inc. | 1.54% | |
| December 6, 2012 | The Goldman Sachs Group, Inc. | 1.37% | |
| December 5, 2012 | The Goldman Sachs Group, Inc. | 1.42% | |
| December 4, 2012 | The Goldman Sachs Group, Inc. | 1.35% | |
| December 3, 2012 | The Goldman Sachs Group, Inc. | 0.97% | |
| November 30, 2012 | The Goldman Sachs Group, Inc. | 1.07% |
Download 163 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in Italy
- Saipem SPA 13.28% of the capital sold short
- Avio SPA 8.94% of the capital sold short
- DoVALUE SPA 7.80% of the capital sold short
- Stellantis NV 6.82% of the capital sold short
- BFF Bank SPA 5.32% of the capital sold short
- Nexi SPA 4.65% of the capital sold short
- Banca Ifis SPA 3.65% of the capital sold short
- Sanlorenzo SPA 3.43% of the capital sold short
- Fincantieri SPA 3.25% of the capital sold short
- Moncler SPA 3.17% of the capital sold short
- Buzzi SPA 3.09% of the capital sold short
- Diasorin SPA 2.61% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, CTI Biopharma Corp, source Consob, data as at June 14, 2017, https://www.quivad.com/action/cti-biopharma-corp?page=4